CCSD Code B2810: Segmental Resection or Quadrantectomy
CCSD Code B2810 covers segmental resection or quadrantectomy, a breast-conserving surgical procedure that removes a defined segment or quadrant of breast tissue. It sits in the CCSD breast chapter alongside B2800 (excision or biopsy of a breast lump), B2820 (wide local excision of a breast lesion), and B2830 (repeat local excision to clear margins). Providers […]
CCSD code 0008B (NK Assay Full Panel): UK billing guide
CCSD code 0008B is the NK Assay Full Panel, a diagnostic blood test listed in Chapter 34 (Pathology) of the CCSD (Clinical Coding and Schedule Development Group) Diagnostic Tests Schedule. It measures natural killer (NK) cell activity and is ordered most often in reproductive immunology, for patients investigated for recurrent miscarriage or repeated implantation failure. […]
CCSD code 0011G: FAP genetic analysis billing guide
CCSD code 0011G is the UK code for FAP genetic analysis (APC gene). Guide to the test, documentation, and insurer billing rules.
CCSD code 0660U: Cotinine level
CCSD code 0660U is the cotinine level (urine) test listed in the CCSD Diagnostic Schedule, the coding system used for UK private healthcare billing. Cotinine is the main metabolite of nicotine, so testing for it confirms recent tobacco or nicotine exposure. This guide covers how 0660U fits within the CCSD Schedule, its clinical uses, documentation […]
CCSD code 0636G: MAI Complex RNA test
CCSD code 0636G is the UK private healthcare diagnostic (pathology) code for the MAI Complex RNA test, listed in Chapter 34 (Pathology) of the CCSD schedule. That schedule is the standard coding system UK private medical insurers use to process claims. This guide walks UK private healthcare providers through billing 0636G: verifying the code, confirming […]
CCSD code 0607U: Billing EMMA endometrial microbiome testing in UK private practice
UK billing administrators searching for CCSD code 0607U often hit a wall. The code identifies EMMA (Endometrial Microbiome Metagenomic Analysis), a molecular diagnostic from Igenomix, in US coding databases and on US payer policy notifications. Reproductive medicine labs use it when submitting claims under American insurance systems. But search the CCSD Schedule of Procedures and […]
CCSD code 0455O: HSV-1 and 2 DNA NAAT test billing guide
CCSD code 0455O is the billing code UK private insurers use for the herpes simplex virus (HSV) type 1 and 2 DNA nucleic acid amplification test (NAAT). It sits within the Clinical Coding and Schedule Development (CCSD) Schedule, the coding framework every major private insurer in the UK uses to price and process claims. This […]
CCSD code 0514G: Myotonic dystrophy (gene) diagnostic test
CCSD code 0514G is the code UK private medical insurers use for the Myotonic dystrophy (gene) diagnostic test, a lab-based genetic test rather than a surgical procedure. This guide covers how the code is classified, which insurers recognize it, and what documentation and consent a claim needs. It also covers how to submit the claim […]
CCSD code 0047G: Billing guide for the pan-cardiomyopathy panel
CCSD code 0047G is the pan-cardiomyopathy panel, a genetic test used in UK private healthcare. Here’s how to document, pre-authorise, and bill it to insurers without denials.
CCSD code 0054S: Beta-mannosidase activity billing guide
CCSD code 0054S covers beta-mannosidase activity – a specialist biochemical pathology test used to help diagnose beta-mannosidosis, a rare inherited enzyme disorder. It is a diagnostic investigation rather than a surgical procedure, and that distinction shapes how the test is requested, performed, and billed in UK private healthcare. This guide explains what the beta-mannosidase activity […]